These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33923432)

  • 1. Ensuring Homogeneity in Powder Mixtures for Pharmaceuticals and Dietary Supplements: Evaluation of a 3-Axis Mixing Equipment.
    Marianni B; Polonini H; Oliveira MAL
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33923432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the mixing effectiveness of a new powder mixer.
    Palmieri GF; Lovato D; Marchitto L; Zanchetta A; Martelli S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):81-8. PubMed ID: 15605601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing.
    de Villiers MM; Van der Watt JG
    Pharm Res; 1994 Nov; 11(11):1557-61. PubMed ID: 7870671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process.
    Song M; de Villiers MM
    Pharm Dev Technol; 2004 Nov; 9(4):387-98. PubMed ID: 15581075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixing of low-dose cohesive drug and overcoming of pre-blending step using a new gentle-wing high-shear mixer granulator.
    Alsulays BB; Fayed MH; Alalaiwe A; Alshahrani SM; Alshetaili AS; Alshehri SM; Alanazi FK
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1520-1527. PubMed ID: 29718720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of residence time of pharmaceutical powder in a continuous mixer with impeller and scraper.
    Tomita Y; Nagato T; Takeuchi Y; Takeuchi H
    Int J Pharm; 2020 Aug; 586():119520. PubMed ID: 32526336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a rotation-revolution mixer for mixing powder-liquid reline material.
    Yamaga Y; Kanatani M; Nomura S
    J Prosthodont Res; 2015 Jan; 59(1):71-8. PubMed ID: 25498204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies.
    Polonini H; Dijkers EC; Ferreira AO; da Silva SL; Araújo PVC; Koulouridas S
    Int J Pharm Compd; 2020; 24(5):426-433. PubMed ID: 32886642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.
    Sivén M; Kovanen S; Siirola O; Hepojoki T; Isokirmo S; Laihanen N; Eränen T; Pellinen J; Juppo AM
    J Pharm Pharmacol; 2017 May; 69(5):593-602. PubMed ID: 27704551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of technological processes for the preparation of tablets with a low content of warfarin by direct compression].
    Muselík J; Franc A; Starková J; Matějková Z
    Ceska Slov Farm; 2014 Oct; 63(5):217-21. PubMed ID: 25354742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug agglomeration and dissolution--what is the influence of powder mixing?
    Kale K; Hapgood K; Stewart P
    Eur J Pharm Biopharm; 2009 May; 72(1):156-64. PubMed ID: 19347972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concrete Mixing Methods and Concrete Mixers: State of the Art.
    Ferraris CF
    J Res Natl Inst Stand Technol; 2001; 106(2):391-9. PubMed ID: 27500029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of powder blending using on-line near-infrared measurements.
    Ufret C; Morris K
    Drug Dev Ind Pharm; 2001 Aug; 27(7):719-29. PubMed ID: 11694020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel micro swirl mixer for producing fine metal oxide nanoparticles by continuous supercritical hydrothermal method.
    Kawasaki S; Sue K; Ookawara R; Wakashima Y; Suzuki A
    J Oleo Sci; 2010; 59(10):557-62. PubMed ID: 20877149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrylic bone-cement. Influence of mixer design and unmixed powder.
    Kurdy NM; Hodgkinson JP; Haynes R
    J Arthroplasty; 1996 Oct; 11(7):813-9. PubMed ID: 8934321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
    Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.